Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss. But along with the fat, many are quietly losing something else: muscle. Unlike fat, muscle doesn ...

Drugs that help people hold on to their muscles while losing fat are becoming one of the hottest trends in biotech.

Thinking about taking Ozempic but worried about losing too much muscle? New clinical trial data might point to a future where that’s no longer a concern. Regeneron Pharmaceuticals announced the ...

You can't go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. While Ozempic can be great ...

An experimental oral drug claims to do the work of medications like GLP-1s without losing muscle mass. The medication just went through phase 1 clinical trials. Doctors explain the new medication and ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? There are two drugs, currently in clinical trials, aiming to help patients ...

Some experts believe that anyone could benefit from GLP-1 medications, as the popular drugs have become more widespread and accessible. Others, however, warn that the decision to take the diabetes and ...

GLP-1 drugs like Ozempic are transforming weight loss, but a new UVA study warns they're not improving a critical measure of health: cardiorespiratory fitness. While these medications help people shed ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." In a perfect world, you'd lose fat while keeping your muscle mass intact. Unfortunately, it's common for ...

A recent article highlights the critical importance of skeletal muscle mass in the context of medically induced weight loss, particularly with the widespread use of GLP-1 receptor agonists. These ...